Daniel M Matagne

Title: The Innovations of Daniel M Matagne

Introduction

Daniel M Matagne is a notable inventor based in Taviers, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for conditions related to histamine levels in the body. With a total of 3 patents to his name, Matagne's work reflects a commitment to advancing medical science.

Latest Patents

Among his latest patents, Matagne has developed a drug aimed at treating affections provoked by elevated histamine levels. This innovative drug targets conditions affecting the gastroduodenal mucosa and allergic reactions. It comprises the reaction product of (+)-catechin with basic amino acids, specifically L-lysine, L-arginine, and L-ornithine. Additionally, he has patented a salt of (+)-catechin formed from the reaction product with these amino acids, which can create a hydrosoluble double salt when combined with another inorganic or organic acid.

Career Highlights

Throughout his career, Matagne has worked with various companies, including Continental Pharma Incorporated and Midit, Société Fiduciaire. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.

Collaborations

Matagne has collaborated with notable individuals in his field, including Paul J Niebes and Joseph L Roba. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Daniel M Matagne's contributions to pharmaceutical innovations demonstrate his dedication to improving health outcomes through scientific advancements. His patents reflect a deep understanding of biochemistry and a commitment to addressing medical challenges.